| Literature DB >> 23273920 |
Sarah Schwitalla1, Paul K Ziegler, David Horst, Valentin Becker, Irina Kerle, Yvonne Begus-Nahrmann, André Lechel, K Lenhard Rudolph, Rupert Langer, Julia Slotta-Huspenina, Franz G Bader, Olivia Prazeres da Costa, Markus F Neurath, Alexander Meining, Thomas Kirchner, Florian R Greten.
Abstract
Loss of p53 is considered to allow progression of colorectal tumors from the adenoma to the carcinoma stage. Using mice with an intestinal epithelial cell (IEC)-specific p53 deletion, we demonstrate that loss of p53 alone is insufficient to initiate intestinal tumorigenesis but markedly enhances carcinogen-induced tumor incidence and leads to invasive cancer and lymph node metastasis. Whereas p53 controls DNA damage and IEC survival during the initiation stage, loss of p53 during tumor progression is associated with increased intestinal permeability, causing formation of an NF-κB-dependent inflammatory microenvironment and the induction of epithelial-mesenchymal transition. Thus, we propose a p53-controlled tumor-suppressive function that is independent of its well-established role in cell-cycle regulation, apoptosis, and senescence.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23273920 DOI: 10.1016/j.ccr.2012.11.014
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743